Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Erleada
Marketing
Bayer falls short in bid to block J&J’s survival claims
In a blow to Bayer, a U.S. federal judge in Manhattan has said he will not block Johnson & Johnson’s survival claims on a key prostate cancer drug.
Ben Adams
Apr 20, 2026 8:24am
Bayer sues J&J over 'deeply flawed' Erleada promotional claims
Feb 23, 2026 1:03pm
J&J's Erleada shows survival edge over Xtandi in real-world study
Oct 2, 2024 2:42pm
J&J touts progress on new launches as Stelara cliff nears
Oct 17, 2023 10:15am
J&J breaks out the blue jacket for prostate cancer awareness
Feb 7, 2023 7:35am
J&J kicks off prostate cancer health disparities campaign
Sep 21, 2022 9:25am
